CLINICAL_TRIALS
trial_result
· 2014-02-25
Clinical Trial Update: Agaricus Blazei Murill in Patients With Multiple Myeloma [Phase 2]
Summary
A phase 2 clinical trial evaluating Agaricus blazei Murill extract in patients with multiple myeloma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ullevaal University Hospital | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED